Mixed-Chirality Prohibitin Peptide: D-(RLARLAR)2 Enhances Stability and <i>In Vivo</i> Effects on Obesity
Article Details
Journal Info
Journal of the American Chemical Society
American Chemical Society
Authors (16)
Lai Yue Chan
Institute for Molecular Bioscience, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science
Benjamin D. Weger
Institute for Molecular Bioscience, Centre for Cell Biology and Chronic Disease
Meltem Weger
Institute for Molecular Bioscience, Centre for Cell Biology and Chronic Disease
Junqiao Du
Institute for Molecular Bioscience, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science
Nicole Lawrence
Institute for Molecular Bioscience, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science
Marlon H. Cardoso
Programa de Pós-Graduação em Ciências Ambientais e Sustentabilidade Agropecuária
Samilla B. de Rezende
S-inova Biotech, Programa de Pós-Graduação em Biotecnologia
Jéssica A.I. Muller
Institute for Molecular Bioscience, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science
Kuok Yap
Institute for Molecular Bioscience, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science
Brian W−C Tse
Preclinical Imaging Facility
Kamil A. Sokolowski
Preclinical Imaging Facility
Robert K.P. Sullivan
Queensland Brain Institute
Jennifer Gunter
Centre for Genomics and Personalised Health
Octávio L. Franco
S-inova Biotech, Programa de Pós-Graduação em Biotecnologia
Frédéric Gachon
Institute for Molecular Bioscience, Centre for Cell Biology and Chronic Disease
David J. Craik
Institute for Molecular Bioscience, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science